Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
In randomized clinical trials (RCTs) of nonvitamin K antagonist oral anticoagulants (NOACs) for acute venous thromboembolism (VTE), similar to 12-13% of patients were elderly and similar to 26% had mild-to-moderate renal impairment. Observational studies are not restricted by the selection and treat...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
Springer
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/34413/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.34413 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.344132022-09-13T08:01:31Z http://eprints.um.edu.my/34413/ Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study Ageno, Walter Casella, Ivan B. Chee, Kok Han Schellong, Sebastian Schulman, Sam Singer, Daniel E. Desch, Marc Tang, Wenbo Voccia, Isabelle Zint, Kristina Goldhaber, Samuel Z. R Medicine (General) In randomized clinical trials (RCTs) of nonvitamin K antagonist oral anticoagulants (NOACs) for acute venous thromboembolism (VTE), similar to 12-13% of patients were elderly and similar to 26% had mild-to-moderate renal impairment. Observational studies are not restricted by the selection and treatment criteria of RCTs. In this ancillary analysis of the RE-COVERY DVT/PE global observational study, we aimed to describe patient characteristics, comorbidities, and anticoagulant therapy for subgroups of age (< or >= 75 years) and renal impairment (creatinine clearance CrCl; estimated with Cockcroft-Gault formula] < 30 severe], 30 to < 50 moderate], 50 to < 80 mild], >= 80 normal] mL/min). Of 6095 eligible patients, 25.3% were aged >= 75 years; 38.2% (1605/4203 with CrCl values) had mild-to-moderate renal impairment. Comorbidities were more common in older patients (73.9% aged >= 75 vs. 58.1% < 75 years) and in those with mild or moderate versus no renal impairment (75.9%, 80.9%, and 59.3%, respectively). At hospital discharge or 14 days after diagnosis (whichever was later), most patients (53.7% and 55.1%, respectively) in both age groups received NOACs; 20.8% and 23.4%, respectively, received vitamin K antagonists, 19.0% and 21.8% parenteral therapy, 2.3% and 3.8% other anticoagulant treatments. Use of NOACs decreased with worsening renal impairment (none 58.5%, moderate 49.6%, severe 25.7%) and, in younger versus older patients with moderate renal impairment (33.1% vs. 56.1%). In routine practice, there are more elderly and renally impaired patients with VTE than represented in RCTs. Decreasing renal function, but not older age, was associated with less NOAC use. Clinical Trial Registration:. Unique identifier: NCT02596230. Graphic abstract Decreasing renal function, particularly in the subgroup with CrCl < 30 mL/min, but not older age, was associated with less use of nonvitamin K antagonist oral anticoagulants (NOACs). Nevertheless, more than half of the older patients with moderate renal impairment received a NOAC as their oral anticoagulant. Springer 2021-04 Article PeerReviewed Ageno, Walter and Casella, Ivan B. and Chee, Kok Han and Schellong, Sebastian and Schulman, Sam and Singer, Daniel E. and Desch, Marc and Tang, Wenbo and Voccia, Isabelle and Zint, Kristina and Goldhaber, Samuel Z. (2021) Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study. Journal of Thrombosis And Thrombolysis, 51 (3). pp. 561-570. ISSN 0929-5305, DOI https://doi.org/10.1007/s11239-020-02239-9 <https://doi.org/10.1007/s11239-020-02239-9>. 10.1007/s11239-020-02239-9 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
R Medicine (General) |
spellingShingle |
R Medicine (General) Ageno, Walter Casella, Ivan B. Chee, Kok Han Schellong, Sebastian Schulman, Sam Singer, Daniel E. Desch, Marc Tang, Wenbo Voccia, Isabelle Zint, Kristina Goldhaber, Samuel Z. Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study |
description |
In randomized clinical trials (RCTs) of nonvitamin K antagonist oral anticoagulants (NOACs) for acute venous thromboembolism (VTE), similar to 12-13% of patients were elderly and similar to 26% had mild-to-moderate renal impairment. Observational studies are not restricted by the selection and treatment criteria of RCTs. In this ancillary analysis of the RE-COVERY DVT/PE global observational study, we aimed to describe patient characteristics, comorbidities, and anticoagulant therapy for subgroups of age (< or >= 75 years) and renal impairment (creatinine clearance CrCl; estimated with Cockcroft-Gault formula] < 30 severe], 30 to < 50 moderate], 50 to < 80 mild], >= 80 normal] mL/min). Of 6095 eligible patients, 25.3% were aged >= 75 years; 38.2% (1605/4203 with CrCl values) had mild-to-moderate renal impairment. Comorbidities were more common in older patients (73.9% aged >= 75 vs. 58.1% < 75 years) and in those with mild or moderate versus no renal impairment (75.9%, 80.9%, and 59.3%, respectively). At hospital discharge or 14 days after diagnosis (whichever was later), most patients (53.7% and 55.1%, respectively) in both age groups received NOACs; 20.8% and 23.4%, respectively, received vitamin K antagonists, 19.0% and 21.8% parenteral therapy, 2.3% and 3.8% other anticoagulant treatments. Use of NOACs decreased with worsening renal impairment (none 58.5%, moderate 49.6%, severe 25.7%) and, in younger versus older patients with moderate renal impairment (33.1% vs. 56.1%). In routine practice, there are more elderly and renally impaired patients with VTE than represented in RCTs. Decreasing renal function, but not older age, was associated with less NOAC use. Clinical Trial Registration:. Unique identifier: NCT02596230. Graphic abstract Decreasing renal function, particularly in the subgroup with CrCl < 30 mL/min, but not older age, was associated with less use of nonvitamin K antagonist oral anticoagulants (NOACs). Nevertheless, more than half of the older patients with moderate renal impairment received a NOAC as their oral anticoagulant. |
format |
Article |
author |
Ageno, Walter Casella, Ivan B. Chee, Kok Han Schellong, Sebastian Schulman, Sam Singer, Daniel E. Desch, Marc Tang, Wenbo Voccia, Isabelle Zint, Kristina Goldhaber, Samuel Z. |
author_facet |
Ageno, Walter Casella, Ivan B. Chee, Kok Han Schellong, Sebastian Schulman, Sam Singer, Daniel E. Desch, Marc Tang, Wenbo Voccia, Isabelle Zint, Kristina Goldhaber, Samuel Z. |
author_sort |
Ageno, Walter |
title |
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study |
title_short |
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study |
title_full |
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study |
title_fullStr |
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study |
title_full_unstemmed |
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study |
title_sort |
profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: re-covery dvt/pe study |
publisher |
Springer |
publishDate |
2021 |
url |
http://eprints.um.edu.my/34413/ |
_version_ |
1744649178554826752 |
score |
13.211869 |